Alpana R Gowda, MD
Physical Medicine and Rehabilitation · Stanford
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 10
- 2 carriers
- Offices
- 3
- Since medical school
- 26 years
- Graduated 2000
On the public record
- Owns Aptos Surgery Center, LLC: Accreditation Lapsed
Offices
3 locations · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
10 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Gowda’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
10 of 10 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A91983 · Current
Licensed to practise in California · since 2005 · expires 2027-07-31 · Wright State University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Aptos Surgery Center, LLCAmbulatory Surgery Center · Aptos, CA3% owner since 2013 · accredited by AAAHCAccreditation Lapsed1 inspection · last 2015-02-10
- Watsonville Surgeons Group, LLC dba Central Coast Surgery CenterAmbulatory Surgery Center · Freedom, CA5.23% owner since 2025 · accredited by AAAHCAccreditation Renewed5 inspections, 2 with deficiencies · last 2025-05-06: Requirements Met
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$31,388
Medicare paid this office $31,388 for 189 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Nerve test | 51 | $8,142 | $160 |
| Return visit (30+ min) | 54 | $7,062 | $99 |
| New patient visit (45+ min) | 38 | $4,350 | $114 |
| Muscle electrical test | 51 | $3,832 | $38 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 16 | $1,881 | $111 |
See all 7 services
| Nerve test | 51 | $8,142 | $160 |
| Return visit (30+ min) | 54 | $7,062 | $99 |
| New patient visit (45+ min) | 38 | $4,350 | $114 |
| Muscle electrical test | 51 | $3,832 | $38 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 16 | $1,881 | $111 |
| Short return visit (20+ min) | 20 | $1,836 | $80 |
| New patient visit (30+ min) | 14 | $1,287 | $92 |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 45 | – | – | – | 13 | 17 |
| Injection of trigger points, 3 or more muscles | 31 | – | – | – | – | – |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 15 | – | – | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
189 Original Medicare patients in 2024. Average age 72 · Under 65 19% · 85 and older 10% · Women 68% · Also on Medicaid 32% · Health risk score 1.37. At or below the middle of the specialty; the typical physical medicine and rehabilitation clinician is at 1.53.
Conditions among them: High blood pressure 69% · Diabetes 31% · Depression 31% · Coronary heart disease 25% · Chronic kidney disease 20% · Cancer 16% · Atrial fibrillation 16% · Heart failure 12% · COPD 10% · Stroke 10%.
The office billed $155,272, Medicare allowed $41,655 and paid $31,388; for 354 services of 17 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 189 | 354 | 72 | 1.37 | $155,272 | $31,388 |
| 2023 | 193 | 320 | 71 | 1.38 | $136,761 | $26,857 |
| 2022 | 132 | 224 | 70 | 1.50 | $93,735 | $16,620 |
| 2021 | 131 | 200 | 70 | 1.47 | $112,103 | $17,034 |
| 2020 | 129 | 171 | 69 | 1.70 | $54,563 | $11,399 |
| 2019 | 289 | 760 | 71 | 1.55 | $213,938 | $56,444 |
| 2018 | 329 | 1,128 | 70 | 1.40 | $327,220 | $82,655 |
| 2017 | 296 | 877 | 69 | 1.43 | $326,935 | $70,757 |
| 2016 | 308 | 625 | 68 | 1.37 | $290,325 | $61,669 |
| 2015 | 256 | 607 | 68 | 1.24 | $265,445 | $55,048 |
| 2014 | 305 | 696 | 67 | 1.29 | $357,836 | $69,146 |
| 2013 | 264 | 555 | 66 | 1.29 | $250,791 | $52,436 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Return visit (30+ min) | 67 | $5,977 | $82 |
| Nerve test | 32 | $5,086 | $159 |
| New patient visit (60+ min) | 20 | $3,122 | $156 |
| New patient visit (45+ min) | 26 | $2,936 | $113 |
| Muscle electrical test | 32 | $2,680 | $42 |
| Long return visit (40+ min) | 17 | $2,092 | $123 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 12 | $1,395 | $107 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 14 | $150 | $10 |
2022: 6 services
| Return visit (30+ min) | 41 | $3,988 | $83 |
| New patient visit (45+ min) | 37 | $3,960 | $107 |
| New patient visit (60+ min) | 13 | $1,991 | $153 |
| Muscle electrical test | 27 | $1,931 | $36 |
| Nerve test | 27 | $1,608 | $60 |
| New patient visit (30+ min) | 11 | $819 | $74 |
2021: 4 services
| Return visit (30+ min) | 45 | $4,561 | $88 |
| New patient visit (45+ min) | 41 | $4,368 | $107 |
| Long return visit (40+ min) | 13 | $1,763 | $136 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 18 | $201 | $11 |
2020: 4 services
| New patient visit (45+ min) | 25 | $2,726 | $109 |
| Return visit (30+ min) | 37 | $2,536 | $67 |
| Short return visit (20+ min) | 43 | $2,395 | $48 |
| New patient visit (30+ min) | 11 | $650 | $59 |
2019: 13 services
| New patient visit (45+ min) | 75 | $9,210 | $123 |
| Return visit (30+ min) | 100 | $9,109 | $71 |
| Nerve test | 43 | $7,284 | $166 |
| Muscle electrical test | 45 | $4,712 | $53 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 38 | $4,464 | $99 |
| Short return visit (20+ min) | 64 | $4,210 | $55 |
| Long return visit (40+ min) | 26 | $3,131 | $104 |
| New patient visit (60+ min) | 20 | $2,703 | $135 |
| Injection of trigger points, 3 or more muscles | 13 | $1,604 | $52 |
| New patient visit (30+ min) | 18 | $1,448 | $80 |
| Short return visit | 22 | $903 | $35 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 55 | $686 | $10 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 13 | $652 | $43 |
2018: 18 services
| New patient visit (45+ min) | 145 | $17,590 | $121 |
| Return visit (30+ min) | 133 | $17,132 | $77 |
| Nerve test | 39 | $7,436 | $191 |
| Short return visit (20+ min) | 86 | $7,410 | $56 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 58 | $7,291 | $104 |
| Muscle electrical test | 40 | $3,734 | $53 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 21 | $2,987 | $88 |
| New patient visit (60+ min) | 17 | $2,341 | $138 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 18 | $2,153 | $94 |
| Long return visit (40+ min) | 20 | $2,014 | $101 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 21 | $1,717 | $51 |
| Injection of lower or sacral spine facet joint using imaging guidance, third and any additional level | 20 | $1,636 | $51 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 95 | $1,352 | $10 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 30 | $1,345 | $43 |
| Injection of trigger points, 3 or more muscles | 15 | $1,264 | $49 |
| Injection of upper or middle spine facet joint using imaging guidance, second level | 18 | $1,242 | $54 |
| Injection of upper or middle spine facet joint using imaging guidance, third and any additional level | 17 | $1,184 | $54 |
| New patient visit (30+ min) | 11 | $949 | $86 |
2017: 14 services
| New patient visit (45+ min) | 116 | $13,812 | $119 |
| Return visit (30+ min) | 102 | $13,123 | $81 |
| Nerve test | 43 | $8,522 | $194 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 46 | $6,256 | $104 |
| Long return visit (40+ min) | 50 | $5,381 | $91 |
| New patient visit (60+ min) | 31 | $4,498 | $145 |
| Short return visit (20+ min) | 52 | $4,069 | $58 |
| Muscle electrical test | 28 | $3,173 | $62 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 19 | $1,961 | $82 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 11 | $1,343 | $96 |
| Injection of lower or sacral spine facet joint using imaging guidance, third and any additional level | 19 | $1,212 | $50 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 19 | $1,150 | $48 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 78 | $1,090 | $10 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 16 | $715 | $42 |
2016: 9 services
| Return visit (30+ min) | 93 | $10,567 | $79 |
| Long return visit (40+ min) | 66 | $9,433 | $110 |
| Nerve test | 52 | $9,373 | $177 |
| New patient visit (45+ min) | 72 | $8,801 | $122 |
| New patient visit (60+ min) | 56 | $8,561 | $153 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 41 | $4,612 | $102 |
| Short return visit (20+ min) | 31 | $1,874 | $52 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 48 | $1,808 | $32 |
| New patient visit (30+ min) | 12 | $931 | $78 |
2015: 14 services
| Return visit (30+ min) | 44 | $7,244 | $83 |
| Nerve test | 38 | $6,518 | $172 |
| Nerve test | 22 | $6,069 | $243 |
| New patient visit (45+ min) | 42 | $5,653 | $135 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 32 | $3,835 | $96 |
| Short return visit (20+ min) | 39 | $3,553 | $56 |
| Muscle electrical test | 19 | $2,904 | $66 |
| New patient visit (60+ min) | 18 | $2,692 | $150 |
| Return visit (30+ min) | 33 | $2,658 | $70 |
| New patient visit (45+ min) | 20 | $2,312 | $116 |
| Long return visit (40+ min) | 21 | $2,246 | $98 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 39 | $1,599 | $31 |
| New patient visit (30+ min) | 20 | $1,545 | $77 |
| Short return visit (20+ min) | 11 | $451 | $41 |
2014: 13 services
| Nerve test | 62 | $15,931 | $253 |
| Muscle electrical test | 62 | $11,587 | $74 |
| New patient visit (45+ min) | 55 | $6,953 | $126 |
| Return visit (30+ min) | 50 | $6,797 | $81 |
| Nerve test | 25 | $4,150 | $166 |
| Return visit (30+ min) | 48 | $3,651 | $65 |
| New patient visit (60+ min) | 17 | $2,430 | $143 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 21 | $2,343 | $102 |
| New patient visit (45+ min) | 22 | $2,297 | $104 |
| Long return visit (40+ min) | 22 | $2,103 | $96 |
| Short return visit (20+ min) | 24 | $1,909 | $58 |
| New patient visit (30+ min) | 11 | $967 | $88 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 22 | $769 | $31 |
2013: 15 services
| Nerve test | 38 | $9,498 | $250 |
| Muscle electrical test | 43 | $5,215 | $68 |
| Long return visit (40+ min) | 33 | $5,021 | $117 |
| New patient visit (60+ min) | 25 | $3,508 | $140 |
| New patient visit (60+ min) | 24 | $3,493 | $146 |
| Return visit (30+ min) | 41 | $3,127 | $65 |
| Nerve test | 18 | $3,008 | $167 |
| Long return visit (40+ min) | 25 | $2,411 | $89 |
| New patient visit (45+ min) | 22 | $2,175 | $99 |
| Return visit (30+ min) | 18 | $1,749 | $79 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 15 | $1,732 | $102 |
| New patient visit (45+ min) | 11 | $1,134 | $103 |
| Short return visit (20+ min) | 23 | $1,056 | $42 |
| Short return visit (20+ min) | 13 | $953 | $60 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 22 | $896 | $32 |
Medicaid work
$148 in 2023
Medicaid paid $148 for 14 billed services this clinician did in 2023, up to 14 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 14 | $148 |
| 2023 | 14 | 1 | 14 | $148 |
| 2021 | 15 | 1 | 14 | $99 |
| 2019 | 14 | 1 | 14 | $757 |
| 2018 | 126 | 3 | 19 | $10,615 |
See the largest Medicaid services in earlier years
2021
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 15 | $99 |
2019
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 14 | $757 |
2018
| Long return visit (40+ min) | 38 | $5,794 |
| Return visit (30+ min) | 38 | $2,614 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 50 | $2,207 |
Drugs they prescribed that Part D paid
$1,844
Pharmacies billed $1,844 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 83) in 2024. At or below the middle of the specialty; the typical physical medicine and rehabilitation clinician is at 12%.
81 generic and fewer than 11 brand-name prescriptions · $1,844 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Pregabalin | 11 | $511 | $46 |
| Gabapentin | 15 | $217 | $14 |
Year by year
| 2024 | 83 | 21 | 0% (0) | None | $1,844 |
| 2023 | 104 | 44 | 14% (15) | None | $8,082 |
| 2022 | 124 | 37 | 9% (11) | None | $10,079 |
| 2021 | 145 | 39 | 10% (14) | 17% | $11,861 |
| 2020 | 256 | 71 | 17% (43) | 8% | $11,657 |
| 2019 | 370 | 91 | 23% (85) | 6% | $21,455 |
| 2018 | 473 | 102 | 37% (173) | 12% | $46,485 |
| 2017 | 591 | 117 | 25% (150) | 8% | $36,482 |
| 2016 | 574 | 129 | 28% (160) | 12% | $41,833 |
| 2015 | 525 | 104 | 28% (148) | 13% | $39,924 |
| 2014 | 486 | 94 | 28% (134) | 20% | $41,717 |
| 2013 | 443 | 85 | 34% (151) | 22% | $38,116 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Duloxetine | 12 | $1,834 | $153 |
2022: 5 drugs
| Azelastine | 17 | $942 | $55 |
| Pregabalin | 15 | $756 | $50 |
| Duloxetine | 15 | $509 | $34 |
| Ipratropium | 11 | $492 | $45 |
| Gabapentin | 12 | $138 | $12 |
2021: 4 drugs
| Alvesco | 18 | $5,251 | $292 |
| Gabapentin | 32 | $470 | $15 |
| Pregabalin | 13 | $198 | $15 |
| Montelukast | 12 | $57 | $5 |
2020: 6 drugs
| Gabapentin | 93 | $1,541 | $17 |
| Pregabalin | 14 | $740 | $53 |
| Baclofen | 12 | $224 | $19 |
| Tizanidine | 15 | $198 | $13 |
| Hydrocodone-Acetaminophen | 15 | $179 | $12 |
| Tramadol | 11 | $47 | $4 |
2019: 7 drugs
| Gabapentin | 122 | $2,661 | $22 |
| Duloxetine | 24 | $595 | $25 |
| Hydrocodone-Acetaminophen | 26 | $571 | $22 |
| Tizanidine | 42 | $381 | $9 |
| Baclofen | 14 | $241 | $17 |
| Naproxen | 16 | $122 | $8 |
| Tramadol | 22 | $65 | $3 |
2018: 13 drugs
| Lyrica | 18 | $13,982 | $777 |
| Suboxone | 12 | $8,234 | $686 |
| Buprenorphine | 11 | $5,661 | $515 |
| Gabapentin | 121 | $2,330 | $19 |
| Hydrocodone-Acetaminophen | 67 | $1,497 | $22 |
| Duloxetine | 32 | $1,045 | $33 |
| Morphine Sulfate Er | 25 | $770 | $31 |
| Oxycodone-Acetaminophen | 11 | $357 | $32 |
| Tizanidine | 15 | $161 | $11 |
| Tramadol | 43 | $145 | $3 |
| Naproxen | 15 | $126 | $8 |
| Topiramate | 13 | $122 | $9 |
| Diazepam | 11 | $31 | $3 |
2017: 12 drugs
| Lyrica | 22 | $9,382 | $426 |
| Butrans | 11 | $5,962 | $542 |
| Gabapentin | 192 | $3,747 | $20 |
| Hydrocodone-Acetaminophen | 62 | $1,690 | $27 |
| Duloxetine | 47 | $1,636 | $35 |
| Morphine Sulfate Er | 31 | $1,176 | $38 |
| Tizanidine | 27 | $292 | $11 |
| Baclofen | 26 | $257 | $10 |
| Topiramate | 22 | $136 | $6 |
| Trazodone | 18 | $108 | $6 |
| Tramadol | 19 | $58 | $3 |
| Omeprazole | 16 | $44 | $3 |
2016: 13 drugs
| Lyrica | 29 | $10,204 | $352 |
| Butrans | 12 | $4,814 | $401 |
| Gabapentin | 138 | $3,639 | $26 |
| Buprenorphine | 17 | $2,675 | $157 |
| Oxycodone-Acetaminophen | 30 | $2,111 | $70 |
| Hydrocodone-Acetaminophen | 52 | $1,608 | $31 |
| Morphine Sulfate Er | 25 | $946 | $38 |
| Fentanyl | 15 | $912 | $61 |
| Duloxetine | 29 | $865 | $30 |
| Tizanidine | 33 | $319 | $10 |
| Methadone | 18 | $315 | $18 |
| Baclofen | 15 | $188 | $13 |
| Omeprazole | 13 | $42 | $3 |
2015: 13 drugs
| Lyrica | 40 | $15,278 | $382 |
| Gabapentin | 139 | $3,412 | $25 |
| Hydrocodone-Acetaminophen | 70 | $1,698 | $24 |
| Lidocaine | 11 | $1,627 | $148 |
| Duloxetine | 14 | $1,208 | $86 |
| Fentanyl | 15 | $1,129 | $75 |
| Oxycodone-Acetaminophen | 17 | $1,055 | $62 |
| Tizanidine | 35 | $712 | $20 |
| Cyclobenzaprine | 18 | $316 | $18 |
| Zolpidem | 15 | $297 | $20 |
| Methadone | 11 | $269 | $24 |
| Omeprazole | 18 | $166 | $9 |
| Tramadol | 13 | $55 | $4 |
2014: 15 drugs
| Celebrex | 28 | $7,165 | $256 |
| Lyrica | 24 | $6,521 | $272 |
| Gabapentin | 108 | $5,756 | $53 |
| Duloxetine | 13 | $4,193 | $323 |
| Lidocaine | 16 | $3,457 | $216 |
| Hydrocodone-Acetaminophen | 49 | $1,268 | $26 |
| Tizanidine | 21 | $711 | $34 |
| Cyclobenzaprine | 14 | $307 | $22 |
| Topiramate | 14 | $283 | $20 |
| Zolpidem | 23 | $249 | $11 |
| Tramadol | 29 | $207 | $7 |
| Methadone | 20 | $180 | $9 |
| Baclofen | 13 | $166 | $13 |
| Omeprazole | 18 | $163 | $9 |
| Amitriptyline | 11 | $44 | $4 |
2013: 9 drugs
| Gabapentin | 117 | $7,622 | $65 |
| Cymbalta | 14 | $7,048 | $503 |
| Lidoderm | 17 | $4,476 | $263 |
| Celebrex | 12 | $2,191 | $183 |
| Oxycodone Hcl-Acetaminophen | 21 | $1,252 | $60 |
| Hydrocodone-Acetaminophen | 48 | $1,091 | $23 |
| Tizanidine | 34 | $968 | $28 |
| Methadone | 31 | $388 | $13 |
| Venlafaxine Hcl Er | 11 | $305 | $28 |
Money from drug and device companies
$168 in 2023
| 2023 | 1 | 2 | None | $168 |
| 2019 | 3 | 4 | None | $67 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| SPR Therapeutics | Sprint Pns System | $168 | 2 payments
|
See all 2 published payments
| SPR Therapeutics | Meals · 2023-09-07 | Sprint Pns System | $71 |
| SPR Therapeutics | Meals · 2023-04-01 | Sprint Pns System | $98 |
See earlier years (2019)
2019: $67
| Lilly USA | Emgality | $24 | 2 payments
|
| Scilex Pharmaceuticals | Ztlido 30 Pouch in 1 Carton 1 Patch in 1 Pouch | $22 | 1 payment
|
| Electronic Waveform Lab | None | $20 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1366575003
- Licence
- CA A91983California A91983: Current · expires 2027-07-31
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2081P2900X (2081P2900X); Federal specialty code 174400000X (174400000X); Federal specialty code 208100000X (208100000X)
- Mailing address
- 850 Freedom Blvd, Watsonville, CA, 95076
- NPI first listed
- 2007-03-13
- NPI last updated
- 2024-04-10
- NPI record certified
- 2024-04-10
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 850 Freedom Blvd, Watsonville, CA, 95076